New Perspectives on Biologic Therapy in Crohn’s Disease

New Perspectives on Biologic Therapy in Crohn’s Disease is organized by Omnia Education.

Released:  10/23/2019
Valid until: 10/23/2020

Accreditation:
Global Learning Collaborative designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™.

Overview:
Amid the ongoing dialogue on the shifting expectations of care in the management of Crohn's disease, Dr. Neil Nandi and Dr. Millie Long review the benefits of early initiation of biologics into the Crohn's disease treatment paradigm.

Learning Objectives:
After participating in this educational activity, participants should be better able to:
• Correlate evolving treatment approaches with treat-to-target strategies according to specific patient-related factors
• Translate emerging and real-world data on comparative efficacy and safety of anti-integrins and anti-TNFs to treatment planning

Additional details will be posted as soon as information is available.